I am a
Home I AM A Search Login

Papers of the Week


Papers: 27 Feb 2021 - 5 Mar 2021


Pharmacology/Drug Development


2021 Mar 03


Expert Opin Drug Saf

Safety of treatment options available for postoperative pain.

Authors

Jin Z, Lee C, Zhang K, Gan TJ, Bergese SD
Expert Opin Drug Saf. 2021 Mar 03.
PMID: 33656971.

Abstract

IntroductionPostoperative pain is one of the most common adverse events after surgery and has been shown to increase the risk of other complications. On the other hand, liberal opioid use in the perioperative period is also associated with risk of adverse events. The current consensus is therefore to provide multimodal, opioid minimizing analgesia after surgery.Areas CoveredIn this review, we will discuss the benefits and risks associated with non-opioid analgesics, including non-steroidal anti-inflammatory drugs, gabapentinoids, ketamine, α-2 agonists and corticosteroids. In addition, we will discuss the general and block specific risks associated with regional anesthestic techniques.Expert OpinionAdverse events associated with non-opioid analgesics are rare outside of their specific contraindicated patient groups, especially when dosed appropriately. α-2 agonists can cause transient hypotension and bradycardia, gabapentinoids may cause sedation in higher risk patient populations. Regional anesthesia techniques are generally safe when done by an experienced practitioner. We therefore encourage the development of standardized multimodal analgesic protocols, which may facilitate opioid minimization and lead to better patient outcomes.